Given that SCs are fast becoming druggable targets [77] and considering that SC removal has already been shown to improve glucose tolerance and enhance insulin sensitivity in obese mice [11], the results presented here encourage the design of further studies [40] testing the effect of SCs removal, or other safe strategies reducing the deleterious effect of SCs, on diabetes-related endpoints in obese subjects. The gene discussed is INS; the disease is diabetes mellitus.